Formulation, Optimization, In Vitro and In Vivo Evaluation of Saxagliptin-Loaded Lipospheres for an Improved Pharmacokinetic Behavior
Open Access
- 20 October 2021
- journal article
- research article
- Published by Hindawi Limited in BioMed Research International
- Vol. 2021, 1-17
- https://doi.org/10.1155/2021/3849093
Abstract
The development and optimization of controlled release lipospheres (LS) from safe biocompatible behenic acid (BA) was performed for not only enhancing patient’s compliance against highly prevailed chronic diabetes but also to vanquish the insufficiencies of traditional methods of drug delivery. The Box-Bhenken design (BBD) was utilized to statistically investigate the impact of formulation variables on percentage yield (), entrapment efficiency (), and SG-release () from saxagliptin- (SG-) loaded LS, and the chosen optimized LS were subjected to a comparative in vivo pharmacokinetic analysis against commercially available SG brand. The compatibility analysis performed by DSC and FTIR established a complete lack of interaction of formulation components with SG, while p-XRD suggested a mild transformation of crystalline drug to its amorphous form during encapsulation process. The spherical, free flowing smooth surface LS having zeta potential of -32 mV and size range of 11-20 μm were conveniently formulated. The obtained data for (30-80%), (30-70%), and (40-90%) showed a best fit with quadratic model. The pharmacokinetics analysis of LS showed a significantly decreased of SG ( ) with a sufficiently elevated (10.53 h) as compared to commercial brand of SG ( and ). The achievement of greater bioavailability of SG was most probably attributed to higher level of half-life, mean residence time (MRT), and AUC0-24 for SG released from LS. Conclusively, the novel approach of SG-loaded LS had successfully sustained the plasma SG level for a prolonged time without increasing which would ultimately bring an effective management of chronic diabetes.This publication has 28 references indexed in Scilit:
- Carnauba wax microparticles produced by melt dispersion techniqueChemical Papers, 2011
- PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft ExcelComputer Methods and Programs in Biomedicine, 2010
- Preparation and characterization of spray-dried mucoadhesive microspheres of aceclofenacDrug Development and Industrial Pharmacy, 2009
- Novel formulation of solid lipid microparticles of curcumin for anti-angiogenic and anti-inflammatory activity for optimization of therapy of inflammatory bowel diseaseJournal of Pharmacy and Pharmacology, 2009
- RP-HPLC estimation of ramipril and telmisartan in tabletsIndian Journal of Pharmaceutical Sciences, 2009
- Lipospheres as Carriers for Topical Delivery of Aceclofenac: Preparation, Characterization and In Vivo EvaluationAAPS PharmSciTech, 2008
- Solid lipid microparticles: formulation, preparation, characterisation, drug release and applicationsExpert Opinion on Drug Delivery, 2005
- Chitosan microspheres as a potential carrier for drugsInternational Journal of Pharmaceutics, 2004
- Development and evaluation of sustained-release propranolol wax microspheresJournal of Microencapsulation, 2001
- Plasma concentration profiles and antihypertensive effect of conventional and extended-release felodipine tablets.British Journal of Clinical Pharmacology, 1990